Until 5 years ago, systemic therapeutic options for urothelial carcinoma, the most common form of bladder cancer, had been…
Leveraging RNA Sequencing Data in Predicting Immunotherapy Response Erin Newburn, MS, PhD Director, Field Application Scientist…
NATIONAL HARBOR, MD. – New research has shown increased immune infiltration in patients with TP53-mutated acute myeloid…
SEATTLE, Nov. 07, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ: NSTG ), a provider of life science tools for…